Last reviewed · How we verify

NCT06697132

Modified Antegrade Stenting in Laparoscopic Pediatric Pyeloplasty; an Optimized Approach

Completed NA Last updated 21 November 2024
What this trial tests

NA trial testing laparoscopic dismembered pyeloplasty in UPJ - Ureteropelvic Obstruction in 75 participants. Completed in 1 August 2021.

Timeline
1 March 2013
Primary endpoint
1 August 2021
1 August 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment75
Start date1 March 2013
Primary completion1 August 2021
Estimated completion1 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 3 to 15, any sex, with UPJ - Ureteropelvic Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background and Rationale For decades, the use of transanastomotic stents following dismembered pyeloplasty has been controversial. However classically, many surgeons used to insert an indwelling DJ stent to secure the ureteropelvic anastomosis. During the laparoscopic pyeloplasty, the DJ can be inserted using different approaches. Neither of these approaches has absolute benefits , nor is free from drawbacks. Objective: Whether the retrograde or antegrade approach of stenting is superior in laparoscopic pyeloplasty remains a great controversy. Each technique has its advantages and disadvantages. We tried in this study to optimize the way of stenting, taking the advantages of both approaches and avoiding their disadvantages.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06697132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing